Skip to main content
. 2023 Jul 17;3:98. doi: 10.1038/s43856-023-00329-2

Fig. 2. Overlap of drugs across categories.

Fig. 2

Supervenn diagram of drug identifier overlap between FDA categories D and X, known placenta crossing drugs, and unique drugs and small molecules within the L1000 LINCS perturbation datasets. Drugs and compounds not represented in the L1000 perturbations are not included in the counts.